v3.26.1
Summary of Significant Accounting Policies (Details Narrative)
12 Months Ended
Dec. 31, 2025
USD ($)
Segment
Dec. 31, 2024
USD ($)
Jul. 01, 2025
USD ($)
Product Information [Line Items]      
FDIC insurance limit $ 250,000    
Cash and unsegregated cash 2,417,721    
Depreciation expenses 287,961 $ 267,382  
Number of shares awarded value     $ 3,000,000
Number of shares granted value     $ 9,200,000
Grants costs $ 1,607,694 2,333,722  
Number of reportable segment | Segment 1    
MDB Capital Holdings LLC [Member]      
Product Information [Line Items]      
Outstanding payable $ 5,330 178,966  
Patents [Member]      
Product Information [Line Items]      
Legal fees 236,731 260,779  
Grant [Member]      
Product Information [Line Items]      
Research and development costs 5,314,685 4,202,488  
Grant [Member] | National Institud of Health and Department of Energy and Department of Defense [Member]      
Product Information [Line Items]      
Grant drawdowns $ 1,569,165 $ 2,235,163  
Department of Energy [Member]      
Product Information [Line Items]      
Government grants percentage 86.00%    
NIH [Member]      
Product Information [Line Items]      
Government grants percentage 14.00%